Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169) |
---|
11/27/2013 | CN102626444B Medicine combination for treating gout and preparing method and application thereof |
11/27/2013 | CN102614406B Traditional Chinese medicine for prevention and treatment of intractable oral mucosal ulcer and preparation method thereof |
11/27/2013 | CN102579978B External traditional Chinese medicine composition for treating scapulohumeral periarthritis |
11/27/2013 | CN102579518B Pterocephalus hookeri (C.B.Clarke) Hoeck total saponin extract and preparation method and application thereof |
11/27/2013 | CN102558298B Method for synthesizing tetrapeptide isomers by using solid phase peptide synthesis method and applications of tetrapeptide isomers |
11/27/2013 | CN102526637B Oral administration Chinese medicinal composition for treating rheumatism |
11/27/2013 | CN102526313B Method for preparing medicinal composition bag stuffing for treating heel pain |
11/27/2013 | CN102516397B Interleukin-17 receptor antagonist and application thereof in preparing anti-myocardial fibrosis medicine |
11/27/2013 | CN102488765B Medicine for treating osseous rheumatism and cerebral apoplexy |
11/27/2013 | CN102421754B Acrylamide derivative and use thereof in manufacture of medicament |
11/27/2013 | CN102397324B Method for determining phenylpropanoid glycoside substances in Tibetmedicine Lamiophlomis rotata |
11/27/2013 | CN102389469B Foot bathing health care medicament |
11/26/2013 | US8592433 Compounds and compositions as protein kinase inhibitors |
11/26/2013 | US8592395 Therapeutic compounds |
11/26/2013 | US8592375 Multifunctional context-activated protides and methods of use |
11/26/2013 | US8591950 Hydrogel implants with varying degrees of crosslinking |
11/26/2013 | CA2731801C Therapeutic formulations for the treatment of cold and flu-like symptoms |
11/26/2013 | CA2649736C Heterocyclic compounds as inhibitors of c-fms kinase |
11/26/2013 | CA2615918C Antibody fragment-polymer conjugates and humanized anti-il-8 monoclonal antibodies |
11/26/2013 | CA2590961C [1h-pyrazolo[3,4-d]pyrimidin-4-yl]-piperidine or -piperazine compounds as serine-threonine kinase modulators (p70s6k, atk1 and atk2) for the treatment of immunological, inflammatory and proliferative diseases |
11/26/2013 | CA2576727C Derivatives of n-(1h-indolyl)-1h-indole-2-carboxamides, their preparation and their application in therapy |
11/26/2013 | CA2567190C Combinations of hyaluronic acid and polyunsaturated fatty acids |
11/26/2013 | CA2535208C Oral compositions and route of administration for the delivery of a thylakoid extract |
11/26/2013 | CA2378562C Method for producing oligopolysaccharides |
11/21/2013 | WO2013173730A2 Novel therapeutic uses of mu-opiate receptor peptides |
11/21/2013 | WO2013173720A1 Piperidinylcyclobutyl substituted pyrrolopyridine and pyrrolopyrimidine derivatives as jak inhibitors |
11/21/2013 | WO2013173330A1 Compositions comprising zoledronic acid or related compounds for relieving inflammatory pain and related conditions |
11/21/2013 | WO2013172999A1 Pharmaceutical compositions for the delivery of substantially water-insoluble drugs |
11/21/2013 | WO2013172838A1 Compositions and methods for hair growth |
11/21/2013 | WO2013172379A1 Novel antibody and application thereof |
11/21/2013 | WO2013172087A1 Composition provided with nitric oxide production-inhibiting activity |
11/21/2013 | WO2013171694A1 Fluorinated bridged spiro[2.4]heptane derivatives as alx receptor agonists |
11/21/2013 | WO2013171166A1 A xanthine derivative as dpp-4 inhibitor for use in the treatment of sirs and/or sepsis |
11/21/2013 | WO2013170972A1 Pharmaceutical composition comprising (1r,4r)-6'-fluoro-n,n-dimethyl-4-phenyl-4',9'-dihydro-3'h-spiro[cyclohexane-1,1'-pyrano [3,4,b]indol]-4-amine and an anticonvulsant |
11/21/2013 | WO2013170971A1 Pharmaceutical composition comprising (1r,4r)-6'-fluoro-n,n-dimethyl-4-phenyl-4',9'-dihydro-3'h-spiro[cyclohexane-1,1'-pyrano [3,4,b]indol]-4-amine and a nsar |
11/21/2013 | WO2013170970A1 Pharmaceutical composition comprising (1r,4r)-6'-fluoro-n,n-dimethyl-4-phenyl-4',9'-dihydro-3'h-spiro[cyclohexane-1,1'-pyrano [3,4,b]indol]-4-amine and an oxicam |
11/21/2013 | WO2013170969A1 Pharmaceutical composition comprising (1r,4r)-6'-fluoro-n,n-dimethyl-4-phenyl-4',9'-dihydro-3'h-spiro[cyclohexane-1,1'-pyrano'[3,4,b]indol]-4-amine and paracetamol or propacetamol |
11/21/2013 | WO2013170968A1 Pharmaceutical composition comprising (1r,4r)-6'-fluoro-n,n-dimethyl-4-phenyl-4',9'-dihydro-3'h-spiro [cyclohexane-1,1'-pyrano-[3,4,b]indol]-4-amine and a salicylic acid component |
11/21/2013 | WO2013170967A1 Pharmaceutical composition comprising (1r,4r)-6'-fluoro-n,n-dimethyl-4-phenyl-4',9'-dihydro-3'h-spiro[cyclohexane-1,1'-pyrano-[3,4,b]indol]-4-amine and a propionic acid derivative |
11/21/2013 | WO2013170966A1 Pharmaceutical composition comprising (1r,4r)-6'-fluoro-n,n-dimethyl-4-phenyl-4',9'-dihydro-3'h-spiro[cyclohexane-1,1'-pyrano [3,4,b]indol]-4-amine and a gabapentinoid |
11/21/2013 | WO2013170965A1 Pharmaceutical composition comprising (1r,4r)-6'-fluoro-n,n-dimethyl-4-phenyl-4',9'-dihydro-3'h-spiro[cyclohexane-1,1'-pyrano [3,4,b]indol]-4-amine and antidepressants |
11/21/2013 | WO2013170711A1 Analgesic pharmaceutical composition |
11/21/2013 | WO2013170367A1 Methods and uses for proprotein convert ase subtilisin kexin 9 (pcsk9) inhibitors |
11/21/2013 | WO2013149211A3 Compositions and treatment methods for mesenchymal stem cell-induced immunoregulation |
11/21/2013 | WO2013032558A4 Products for anti-inflammation support |
11/21/2013 | US20130310562 Bicyclic Heteroaromatic Compounds As Protein Tyrosine Kinase Inhibitors |
11/21/2013 | US20130310388 Modulators of TNF-Alpha Signaling |
11/21/2013 | US20130310335 Prolonged release bioadhesive therapeutic systems |
11/21/2013 | US20130310320 Boronic ester and acid compounds, synthesis and uses |
11/21/2013 | US20130309232 Vascular endothelial growth factor 2 |
11/21/2013 | US20130309215 Pharmaceutical composition |
11/20/2013 | EP2664340A2 A direct drug delivery system based on thermally responsive biopolymers |
11/20/2013 | EP2664328A1 Omega3 fatty acid compound preparation |
11/20/2013 | EP2663550A2 Substituted benzoazepines as toll-like receptor modulators |
11/20/2013 | EP2663307A1 Anti-angiogenic compound |
11/20/2013 | EP2408740B1 Compounds for treating inflammation and pain |
11/20/2013 | EP2334672B1 4,5,6,7-Tetrahydroimidazo[4,5-c]pyridine compounds as inhibitors of SSAO |
11/20/2013 | EP2300437B1 Benzpyrazol derivatives as inhibitors of pi3 kinases |
11/20/2013 | EP2272869B1 Angiopoietin-2 specific binding agents |
11/20/2013 | EP2220029B1 Benzamide compounds and their use as prostaglandin E4 receptor agonists |
11/20/2013 | EP2202227B1 Novel histidine derivative |
11/20/2013 | EP2200595B1 Thieno-and furo-pyrimidine modulators of the histamine h4 receptor |
11/20/2013 | EP2108655B1 Immune-modulating peptide |
11/20/2013 | EP1881982B1 Imidazolone phenylalanine derivatives as vla-4 antagonists |
11/20/2013 | EP1801108B9 Morpholine compounds for the treatment of inflammations |
11/20/2013 | CN103402987A 6-amino-2-phenylamino-1H-benzimidazole-5-carboxamide- derivatives and their use as microsomal prostaglandin E2 synthase-1 inhibitors |
11/20/2013 | CN103402986A Modulators of S1P receptors |
11/20/2013 | CN103402520A Substituted imidazoquinoline derivatives |
11/20/2013 | CN103402499A Methods of producing stabilized solid dosage pharmaceutical compositions containing morphinans |
11/20/2013 | CN103402376A Human milk oligosaccharides to promote growth of beneficial bacteria |
11/20/2013 | CN103396489A Engineered anti-IL-23p19 antibodies |
11/20/2013 | CN103396473A Cxcr4 receptor compound |
11/20/2013 | CN103396409A Pyrimidyl cyclopentanes as AKT protein kinase inhibitors |
11/20/2013 | CN103396398A Prokineticin 1 receptor antagonists |
11/20/2013 | CN103396302A Alpha-cyperone and preparation method of preparation thereof |
11/20/2013 | CN103396300A Quinolinone compound, a process for producing same and use thereof as anti-inflammatory agent |
11/20/2013 | CN103394091A Analgesic anti-inflammatory preparation for external application |
11/20/2013 | CN103394078A Self-pressurized multi-target collaborative hemostasis degradable hemostatic preparation for injury first aid |
11/20/2013 | CN103394069A Traditional Chinese medicine composition for treating ankylosing spondylitis and preparation method thereof |
11/20/2013 | CN103394064A Traditional Chinese medicine composition used for treating slight cold |
11/20/2013 | CN103394062A Externally used compound traditional Chinese medicine for treating cancer induced bone pain |
11/20/2013 | CN103394058A Medicament for treating postpartum disease and preparation method thereof |
11/20/2013 | CN103394056A Traditional Chinese medicine containing liquorice and preparation method thereof |
11/20/2013 | CN103394055A Traditional Chinese medicine containing nux vomica powder and preparation method thereof |
11/20/2013 | CN103394051A Rhizoma corydalis-angelica powder and preparation method thereof |
11/20/2013 | CN103394050A Rhizoma corydalis-angelica capsule and preparation method thereof |
11/20/2013 | CN103394049A Rhizoma corydalis-angelica ointment and preparation method thereof |
11/20/2013 | CN103394048A Rhizoma corydalis-angelica water-paste pill and preparation method thereof |
11/20/2013 | CN103394031A Medicament for treating sciatica |
11/20/2013 | CN103394028A Bruising internal injury first-aid Chinese herbal medicine composition and preparation method thereof |
11/20/2013 | CN103394013A Traditional Chinese medicine containing corydalis tuber and preparation method thereof |
11/20/2013 | CN103394011A Chinese medicinal preparation for treating acute gastroenteritis |
11/20/2013 | CN103394009A Traditional Chinese medicine for treating trauma and diabetes foot ulcer and preparation method |
11/20/2013 | CN103393999A Anti-inflammatory resolutive liquid medicine for promoting blood circulation to arrest pain |
11/20/2013 | CN103393950A Tradtional Chinese medicine composition for treating bone fracture and preparation method thereof |
11/20/2013 | CN103393939A Oral liquid for inflammation diminishing and pain relieving |
11/20/2013 | CN103393932A Medicinal liquor for treating rheumatism |
11/20/2013 | CN103393931A Traditional Chinese medicine liquor |
11/20/2013 | CN103393914A Drug for treating gingival pain and swelling |
11/20/2013 | CN103393908A Product for treating systemic lupus erythematosus and rheumatism and preparation method thereof |